Stocks
Arrowhead Pharmaceuticals (ARWR) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| ROE, % | ? | -34.5% | -44.2% | -75.7% | -323.3% | -0.35% | -49.0% | ||
| Changes by years, y/y, % | -16pp | -10pp | -31pp | -248pp | +323pp | -96% | |||
Arrowhead Pharmaceuticals. ROE, %
Arrowhead Pharmaceuticals. ROE, changes, pp
Arrowhead Pharmaceuticals (ARWR) ROE US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q3 | LTM ? | |||
| ROE, % | ? | -28.4% | -0.35% | 35.6% | -49.0% | -68.7% | -49.0% | |
| Changes by years, y/y, % | +135pp | +323pp | +1 252pp | -28pp | -40pp | |||
| Changes by quarters, q/q, % | -7pp | +28pp | +36pp | -85pp | -20pp | |||
